# Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects

> **NCT04760951** · NA · COMPLETED · sponsor: **Valbiotis** · enrollment: 120 (actual)

## Conditions studied

- Hypercholesterolemia
- Cardiovascular Risk Factor
- Dyslipidemias
- Overweight and Obesity
- Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** TOTUM-070
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04760951
- **Lead sponsor:** Valbiotis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-17
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-02-17
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760951, "Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04760951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*